FDA Circular No. 2020-007 || GUIDELINES IN THE IMPLEMENTATION OF THE USE OF ELECTRONIC MEANS OF PRESCRIPTION FOR DRUGS FOR THE BENEFIT OF INDIVIDUALS VULNERABLE TO COVID-19

This Circular shall apply to all individuals vulnerable to COVID-19 as defined under this Circular and to all licensed physicians authorized to prescribe drugs to the aforementioned individuals. The same Circular shall cover all Drugstore/Pharmacy/Botica and similar outlets, but shall not include prescription that requires PDEA S-2 license.

READ MORE–>FDA Circular No. 2020-007

Para sa karagdagang impormasyon  sa Circular No. 2020-007, narito ang pahayag ng FDA patungkol dito. BASAHIN —> http://bit.ly/33tbTEQ

/ In Circular / By Administrator / Comments Off on FDA Circular No. 2020-007 || GUIDELINES IN THE IMPLEMENTATION OF THE USE OF ELECTRONIC MEANS OF PRESCRIPTION FOR DRUGS FOR THE BENEFIT OF INDIVIDUALS VULNERABLE TO COVID-19